SynthesisScientific reports2018

Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women.

Sara S Oltra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.